We discuss the state of the art and innovative micro-and nanoscale technologies that are
finding niches and opening up new opportunities in medicine, particularly in diagnostic and …

Due to the vastness of the science virology, it is no longer an offshoot solely of the
microbiology. Viruses have become as the causative agents of major epidemics throughout …

Microfluidic diagnostic devices have the potential to transform the practice of medicine. We
engineered a multiplexed digital–analog microfluidic platform for the rapid and highly …

We report on a supramolecular sensor array using fluorogenic peptide probes and
graphene oxide that can target glycoproteins on a viral caspid, facilitating the differentiation …

Massive worldwide serological testing for SARS-CoV-2 is needed to determine the extent of
virus exposure in a particular region, the ratio of symptomatic to asymptomatic infected …

Antibodies have been used for basic research, clinical diagnostics, and therapeutic
applications. Escherichia coli is one of the organisms of choice for the production of …

The 2014 Ebola outbreak, the largest recorded, took us largely unprepared, with no
available vaccine or specific treatment. In this context, the World Health Organization …

There is a pressing need for sustainable and sensitive immunodiagnostics for use in public
health efforts to understand and combat the threat of endemic and emerging infectious …

Mycotoxin contamination of food and feed is now ubiquitous. Exposures to mycotoxin via
contact or ingestion can potentially induce adverse health outcomes. Affordable mycotoxin …

Vectored delivery of the ZMapp antibody cocktail (c2G4, c4G7, and c13C6) by using
recombinant adeno-associated viruses (rAAVs) could be useful for preventive immunization …